Nav: Home

23andMe, NIH work to reduce health research disparities among African Americans

October 13, 2016

Mountain View, California - October 13, 2016 - 23andMe, Inc., the leading personal genetics company, today announced a new grant from the National Institutes of Health (NIH), for the creation of a genetic resource for health research in African Americans that could improve the understanding of diseases in minority populations.

The $1.7 million grant, issued from the National Human Genome Research Institute, will go toward leveraging 23andMe's data on more than one million customers who have consented to participate in research, creating an African American sequencing panel to be used as a reference dataset for health research. The de-identified genetic data will be made available to other health researchers at institutions around the world.

"This project aims to help address health research disparities, specifically for African Americans," said the project's Principal Investigator, Adam Auton, a 23andMe senior scientist and statistical geneticist. "The hope is that this work will help improve our understanding of disease-causing genetic variants in minority populations, and that this in turn could improve treatments among people with non-European ancestry that have historically been underrepresented in health studies."

Some estimates from five years ago showed that more than 90 percent of the research into the genetics underlying disease has been conducted on people of European ancestry. In a commentary published in Nature researchers from the University of Washington say that there has been some progress, but not much. While there are more genome-wide association studies being done on non-Europeans, the degree to which people of African, Latino or Native American ancestry have been studied has barely changed. This week a new study by researchers from the University of Maryland School of Medicine lays out the stark implications of that bias that limits the ability to treat minority populations.

But 23andMe researchers believe they can address this disparity. Within the company's customer base are a very large number of people with non-European ancestry, who have also consented to participate in research. By sequencing the genomes of African American 23andMe customers, our scientists hope to spur more health research on disease affecting minority populations.

When a customer of 23andMe sends in their saliva sample, they are genotyped at hundreds of thousands of sites that are known to vary between individuals. However, there are tens of millions of variable sites in the genome that are not genotyped. By having access to a large number of fully sequenced genomes -- a sequence panel -- researchers are able to depend on a standard method called "genotype imputation" to infer or predict the genotypes at these unobserved positions. Much like a code breaker filling in missing letters in a message, scientists -- using algorithms and data from whole genome sequence panels -- can predict, or impute, the missing letters of genetic data. A very simplified example of the same basic idea would be to fill in the blanks of this phrase: "I l_ve N_w Y_rk."

This process of using large numbers of sequenced genomes together with imputation is what powers most genome-wide association studies today. It allows scientists to glean much more information on the data they have without the cost of having to do whole genome sequencing on everyone participating in a study. This, in turn, allows them to do much larger studies that can reveal more about the disease or trait being studied.

The problem is that most sequenced genomes available today are predominantly for people of European ancestry, limiting the accuracy of imputation for non-Europeans. But because of the large number of 23andMe customers who have consented to research -- including tens of thousands of African Americans --scientists will be able to create a new panel of sequenced African American genomes. Under this grant, 23andMe researchers will ask a subset of our African American customers who have consented to participate in research if they would be willing to participate and have their DNA sequenced to become part of this panel. Ultimately, the sequence panel data will be shared with the NIH, who will make it available to other researchers. This in turn will expand scientists' ability to make genetic discoveries for African Americans and help build a broader understanding of how genetics influence diseases and traits across multiple populations.

This is the latest in a number of efforts by 23andMe to help alleviate some of the existing disparities in genetic research. In April of this year, 23andMe was awarded another NIH grant to use "admixture mapping" as a means to improve the detection of disease-causing genetic variants among people of African, Latino and Asian ancestry. In 2011, 23andMe launched its Roots into the Future® project to study the genetics of disease specific to African Americans. This fall, the company has created an African Genetic Project to recruit people from sub-Saharan Africa, that, among, other things, will improve our knowledge of African genetic diversity.

"We want everyone to benefit from advances in genetic science," said Anne Wojcicki, 23andMe CEO and co-Founder. "We know that there is a huge disparity in health-related genetic research and now we have an opportunity to help change that and ensure that the study of disease and the development of drugs will benefit us all, no matter what our ethnicities."
You can read more about this grant, A New Reference Panel To Boost African American Genotype Imputation, (#1R44 HG009460) on the NIH's website here. The projects described above are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.

About 23andMe

23andMe, Inc. is the leading personal genetics company. Founded in 2006, the mission of the company is to help people access, understand and benefit from the human genome. 23andMe has over one million customers worldwide with over 80 percent consented to participate in research. 23andMe, Inc. is located in Mountain View, CA. More information is available at

23andMe, Inc.

Related Genetics Articles:

Improve evolution education by teaching genetics first
Evolution is a difficult concept for many students at all levels, however, a study publishing on May 23 in the open access journal PLOS Biology has demonstrated a simple cost-free way to significantly improve students' understanding of evolution at the secondary level: teach genetics before you teach them evolution.
Study unravels the genetics of childhood 'overgrowth'
Researchers have undertaken the world's largest genetic study of childhood overgrowth syndromes -- providing new insights into their causes, and new recommendations for genetic testing.
Could genetics influence what we like to eat?
Gene variants could affect food preferences in healthy people, according to a new study.
Reverse genetics for rotavirus
Osaka University scientists generate a new plasmid-based reverse genetics system for rotaviruses.
The genetics behind being Not Like Daddy
A common strategy to create high-yielding plants is hybrid breeding.
Understanding the genetics of human height
A large-scale international study involving more than 300 researchers, published today in Nature, heralds the discovery of 83 genetic variations controlling human height.
Animal genetics: The bovine heritage of the yak
Though placid enough to be managed by humans, yaks are robust enough to survive at 4,000 meters altitude.
New genetics clues into motor neuron disease
Researchers at the University of Queensland have contributed to the discovery of three new genes which increase the risk of motor neuron disease, opening the door for targeted treatments.
Your best diet might depend on your genetics
If you've ever seen a friend have good results from a diet but then not been able to match those results yourself, you may not be surprised by new findings in mice that show that diet response is highly individualized.
Using precision-genetics in pigs to beat cancer
Because of their similarities to people, using new technology in pigs turn up as a valuable alternative to rodent models of cancer.

Related Genetics Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...